药物信息为Femring (estradiol acetate vaginal ring) (Warner Chilcott (US), LLC): TRADE CARTON - Femring 0.10 mg
- WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS AND PROBABLE DEMENTIA FOR ESTROGEN-ALONE THERAPY
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- WARNINGS
- ADVERSE REACTIONS
- OVERDOSAGE
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- STORAGE
- PATIENT INFORMATION
- TRADE CARTON - Femring 0.05 mg
- SAMPLE CARTON - Femring 0.05 mg
- TRADE CARTON - Femring 0.10 mg
- SAMPLE CARTON - Femring 0.10 mg
- 外部链接相关的Femring (estradiol acetate vaginal ring) (Warner Chilcott (US), LLC)

Femring
(estradiol acetate vaginal ring)
0.10 mg/day
Physician's Sample-Not For Sale
Rx ONLY
(Contains 24.8 mg estradiol acetate to deliver the equivalent of 0.10 mg estradiol per day for three months.)
Other ingredients: barium sulfate and cured elastomer.
Store at 25oC (77oF); excursions permitted to 15o - 30oC (59o - 86oF).
[see USP Controlled Room Temperature]
For intravaginal use only.
CONTENTS: 1 VAGINAL RING
- Drug Information Provided by National Library of Medicine (NLM).
